Why Insurance Deserves a Look Alongside Everything Else
Amid the operational and compliance focus of the CR extension period, insurance and risk management considerations often get less attention than they deserve. Given how directly hemp's regulatory status affects insurability, this is worth a dedicated look.
How Regulatory Status Affects Hemp Insurance
Insurance carriers price risk based partly on regulatory clarity. The November 12 uncertainty made some carriers more cautious about hemp-related coverage, either through higher premiums, more restrictive policy terms, or in some cases declining to write new hemp-related policies at all. The CR extension's protected status through December 11 may improve underwriting conditions, but operators should not assume this happens automatically without direct conversation with their carriers.
Key Insurance Categories for Hemp Operators
General liability. Standard business liability coverage, but hemp-specific riders or endorsements may be necessary given some carriers' general caution around cannabis-adjacent industries.
Product liability. Particularly important given the compliance stakes discussed throughout this publication. Product liability coverage should account for the specific claims risk of hemp products, including claims related to mislabeled THC content or inadequate testing documentation.
Directors and officers (D&O) coverage. For hemp companies with formal governance structures, D&O coverage protects leadership from claims related to business decisions, including decisions made during regulatory uncertainty periods like the run-up to November 12 or the current December 11 window.
Property and business interruption. Standard coverage categories that still matter for hemp operators, though some carriers apply hemp-specific exclusions or limitations worth reviewing carefully.
Questions to Ask Your Insurance Broker Right Now
- Has the CR extension changed our underwriting terms or premium calculations?
- What does our policy specifically say about coverage in the event of a December 11 regulatory change?
- Are there specific product categories (certain novel cannabinoids, for example) that carry different coverage terms or exclusions?
- What documentation does our carrier want to see to support favorable underwriting, and does our current COA and compliance documentation meet that standard?
Building a December 11 Risk Management Plan
Beyond insurance specifically, a broader risk management approach for the December 11 window should include: documented compliance practices that support both regulatory defense and insurance underwriting, clear internal protocols for responding to a December 11 outcome that requires product changes, and legal counsel relationships that can move quickly if enforcement action or product liability claims arise.
Why This Matters Beyond the Immediate Window
The insurance and risk management practices you build now, robust documentation, clear compliance protocols, strong carrier relationships, remain valuable regardless of which December 11 outcome occurs. This is infrastructure investment that pays off across multiple possible futures, not a one-time reaction to current uncertainty.
Low Gravity Hemp's full-panel COA documentation and compliance practices are built to support the kind of underwriting and risk management standards insurance carriers look for. Contact us to talk through how our documentation can support your risk management conversations.
